Natural History of Asymptomatic COVID-19 Infection

Information on the natural history of asymptomatic infection with the new coronavirus (COVID-19) remains scarce. We are just beginning to understand what happens with patients with severe disease.

Manejo de los infartos durante la pandemia de Covid-19

The outbreak of COVID-19 on the cruise ship Diamond Princess provided a unique opportunity to study contacts and patients with asymptomatic infection within a closed population. This would have been impossible outside a cruise ship.

Among the 3711 on-board individuals (passengers and crew members included), approximately 712 had a positive COVID-19 test result, but more than half of them (58%) were asymptomatic. From this data, the natural history of asymptomatic patients could be described.

About 11 people who had a polymerase-chain-reaction (PCR) positive test result and were asymptomatic at the time the ship arrived developed symptoms a median of 4 days later, so they were actually presymptomatic. The risk of being presymptomatic increased with increasing age.

Eight cabinmates with a negative PCR test when the ship arrived had a positive PCR test within 72 hours. These people remained asymptomatic.


Read also: Asymptomatic Severe Aortic Stenosis, When Should We Intervene?


Researchers were able to analyze the cohort of people who had a positive PCR test and remained asymptomatic throughout the infection (until they had a negative PCR testing result).

Almost a third of this cohort presented risk factors such as hypertension or diabetes.

The median number of days between the first positive PCR test (either on the ship or at the hospital) and the first of the two serial negative PCR tests was 9 days (range, 3 to 21 days).


Read also: Intervention in Congenital Heart Disease.


In almost half the population (48%) the infection was resolved after 8 days, and almost all patients (90%) were infection-free after 15 days.

The rate of delayed resolution of infection increased with increasing age. The older the patient, the greater the chances of developing symptoms and, if asymptomatic, greater the chances of a delayed resolution of infection.

Original Title: Natural History of Asymptomatic SARS-CoV-2 Infection.

Reference: N Engl J Med. 2020 Aug 27;383(9):885-886. doi: 10.1056/NEJMc2013020.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Is the Booster Dose Against COVID-19 Effective for All Ages?

The answer is incontrovertible: it is undeniably effective. For all ages, the confirmed COVID19 and severe case rates were significantly lower for patients who...

Pfizer Booster Dose Efficacy against Omicron

The BNT162b2 vaccine (Pfizer/BioNTech) has previously shown a 95% efficacy against COVID-19. This efficacy has been changing with the surge of new variants and,...

Once Again, the Omicron Variant Tests the Limits of Healthcare Systems, But with Hope

The latest significant COVID-19 variant, the Omicron, is again pushing healthcare systems around the world onto the verge of collapse, having reached over 300...

The Most Read Articles of 2021: COVID-19

A new year is coming to an end and at SOLACI we are going over the most read studies on our website, on COVID-19. Follow...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....